Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer

This study has been terminated.
(Investigator decision)
Sponsor:
Collaborators:
Translational Genomics Research Institute, Phoenix, Arizona.
Information provided by (Responsible Party):
Oncothyreon Inc.
ClinicalTrials.gov Identifier:
NCT00417287
First received: December 29, 2006
Last updated: April 30, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 30, 2015